NIH-funded research R01 grant

Genetics of methamphetamine use disorder in Thailand (human-focused gene studies)

Official title: Methamphetamine and Other Substance Use Disorder Genetics in Thailand

Funded at Yale University · NIH-11323542 · Data updated 2026-11-12

A research project in Thailand will study how genetic factors relate to methamphetamine use disorder among people in treatment facilities and the community.

More Substance Use research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJune 15, 2015
Project endApril 30, 2028
Funding year2026
Award (this year)$599,424
NIH project number5R01DA037974-09
Project IDNIH-11323542 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with methamphetamine use disorder or at risk individuals in Thailand, plus matched controls, who can provide consent and biological samples.

Less likely to help

People who do not have or are not at risk for methamphetamine use disorder or who cannot participate due to consent or logistical reasons may not benefit.

What this research studies

Researchers funded by NIH will recruit thousands of participants in Bangkok and Chiang Mai to collect genetic samples and information about methamphetamine use and related conditions. The study builds on established collaborations in Thailand and will create a biobank to enable future genetic analyses of MUD and other psychiatric traits. This work involves people who have or are at risk for substance use disorders and will use participant data and samples to understand genetic contributions and potential biologic pathways. Results could guide future prevention and treatment approaches for MUD and related conditions.

Why it matters

Potential benefit: If successful, findings could inform personalized prevention and treatment strategies for methamphetamine use disorder.

How similar studies have gone: Past studies have successfully collected large biobanks and genetic data on substance use disorders showing feasibility in similar settings.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Gelernter, Joel — Yale University
  • Study coordinator: Gelernter, Joel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.